BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22407918)

  • 21. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
    Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y
    J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity.
    Li Y; Zhao C; Liu J; Lu Z; Lu M; Gu J; Liu R
    Oncol Rep; 2019 May; 41(5):2679-2688. PubMed ID: 30864713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
    Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
    Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
    Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
    J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis.
    Kyriakakis E; Cavallari M; Andert J; Philippova M; Koella C; Bochkov V; Erne P; Wilson SB; Mori L; Biedermann BC; Resink TJ; De Libero G
    Eur J Immunol; 2010 Nov; 40(11):3268-79. PubMed ID: 21061446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD1d-restricted IFN-γ-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1α production and activation of macrophages and dendritic cells.
    Kim JH; Chung DH
    J Immunol; 2011 Feb; 186(3):1432-41. PubMed ID: 21191075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor γ-regulated cathepsin D is required for lipid antigen presentation by dendritic cells.
    Nakken B; Varga T; Szatmari I; Szeles L; Gyongyosi A; Illarionov PA; Dezso B; Gogolak P; Rajnavolgyi E; Nagy L
    J Immunol; 2011 Jul; 187(1):240-7. PubMed ID: 21632707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction.
    Mizuuchi K; Yanagawa Y; Iwabuchi K; Namba K; Kitaichi N; Ohno S; Onoé K
    Immunology; 2008 May; 124(1):102-11. PubMed ID: 18194275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo.
    Chung Y; Kim BS; Kim YJ; Ko HJ; Ko SY; Kim DH; Kang CY
    Cancer Res; 2006 Jul; 66(13):6843-50. PubMed ID: 16818662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.
    Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P
    J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
    Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.
    Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK
    J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.
    Corgnac S; Perret R; Zhang L; Mach JP; Romero P; Donda A
    J Immunother Cancer; 2014; 2(1):39. PubMed ID: 25426294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
    Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
    Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.